Rekha Hemrajani

Insider Reports History

Entity
Individual
Location
3928 Point Eden Way, Hayward, CA
Signature
/s/ Dov A. Goldstein as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rekha Hemrajani:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. Director Common Stock 21.4K $105K $4.90 Jun 11, 2024 Direct
MAXCYTE, INC. Director Stock Option (right to buy) 40.7K Jun 11, 2024 Direct
BioAge Labs, Inc. Director Stock Option (Right to Buy) 28.5K Apr 17, 2024 Direct
ALX ONCOLOGY HOLDINGS INC Director Stock Option (right to buy) 20.2K Jun 13, 2024 Direct

Insider Reports Filed by Rekha Hemrajani

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BIOA BioAge Labs, Inc. Sep 25, 2024 0 $0 3 Sep 25, 2024 Director
ALXO ALX ONCOLOGY HOLDINGS INC Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
MXCT MAXCYTE, INC. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
BIOA BioAge Labs, Inc. Apr 17, 2024 2 $0 4 Sep 27, 2024 Director
MXCT MAXCYTE, INC. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
ALXO ALX ONCOLOGY HOLDINGS INC Jun 20, 2023 1 $0 4 Jun 22, 2023 Director
MXCT MAXCYTE, INC. Mar 20, 2023 1 $0 4 Mar 21, 2023 Director
MXCT MAXCYTE, INC. Jun 29, 2022 1 $0 4 Jul 8, 2022 Director
ALXO ALX ONCOLOGY HOLDINGS INC Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
MXCT MAXCYTE, INC. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
MXCT MAXCYTE, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
ALXO ALX ONCOLOGY HOLDINGS INC Jun 11, 2021 1 $0 4 Jun 15, 2021 Director